Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study.

Patkar AA, Rozen S, Mannelli P, Matson W, Pae CU, Krishnan KR, Kaddurah-Daouk R.

Psychopharmacology (Berl). 2009 Oct;206(3):479-89. doi: 10.1007/s00213-009-1625-1. Epub 2009 Aug 1.

PMID:
19649617
2.

Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity.

Pavón FJ, Araos P, Pastor A, Calado M, Pedraz M, Campos-Cloute R, Ruiz JJ, Serrano A, Blanco E, Rivera P, Suárez J, Romero-Cuevas M, Pujadas M, Vergara-Moragues E, Gornemann I, Torrens M, de la Torre R, Rodríguez de Fonseca F.

Addict Biol. 2013 Nov;18(6):955-69. doi: 10.1111/adb.12107. Epub 2013 Nov 14.

PMID:
24283982
3.

Opioid use affects antioxidant activity and purine metabolism: preliminary results.

Mannelli P, Patkar A, Rozen S, Matson W, Krishnan R, Kaddurah-Daouk R.

Hum Psychopharmacol. 2009 Dec;24(8):666-75. doi: 10.1002/hup.1068.

4.

Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.

Gevi F, Zolla L, Gabriele S, Persico AM.

Mol Autism. 2016 Nov 24;7:47. eCollection 2016.

5.

Alterations in metabolic pathways and networks in Alzheimer's disease.

Kaddurah-Daouk R, Zhu H, Sharma S, Bogdanov M, Rozen SG, Matson W, Oki NO, Motsinger-Reif AA, Churchill E, Lei Z, Appleby D, Kling MA, Trojanowski JQ, Doraiswamy PM, Arnold SE; Pharmacometabolomics Research Network.

Transl Psychiatry. 2013 Apr 9;3:e244. doi: 10.1038/tp.2013.18.

6.

Global and targeted serum metabolic profiling of colorectal cancer progression.

Long Y, Sanchez-Espiridion B, Lin M, White L, Mishra L, Raju GS, Kopetz S, Eng C, Hildebrandt MAT, Chang DW, Ye Y, Liang D, Wu X.

Cancer. 2017 Oct 15;123(20):4066-4074. doi: 10.1002/cncr.30829. Epub 2017 Jun 22.

PMID:
28640361
7.

Purine metabolism in women with primary gout.

Puig JG, Mateos FA, Miranda ME, Torres RJ, de Miguel E, Pérez de Ayala C, Gil AA.

Am J Med. 1994 Oct;97(4):332-8.

PMID:
7942934
8.

Metabolomic changes in autopsy-confirmed Alzheimer's disease.

Kaddurah-Daouk R, Rozen S, Matson W, Han X, Hulette CM, Burke JR, Doraiswamy PM, Welsh-Bohmer KA.

Alzheimers Dement. 2011 May;7(3):309-17. doi: 10.1016/j.jalz.2010.06.001. Epub 2010 Nov 13.

9.

Impaired functional connectivity within and between frontostriatal circuits and its association with compulsive drug use and trait impulsivity in cocaine addiction.

Hu Y, Salmeron BJ, Gu H, Stein EA, Yang Y.

JAMA Psychiatry. 2015 Jun;72(6):584-92. doi: 10.1001/jamapsychiatry.2015.1.

PMID:
25853901
10.

Downregulation of Tryptophan-related Metabolomic Profile in Rheumatoid Arthritis Synovial Fluid.

Kang KY, Lee SH, Jung SM, Park SH, Jung BH, Ju JH.

J Rheumatol. 2015 Nov;42(11):2003-11. doi: 10.3899/jrheum.141505. Epub 2015 Sep 1.

PMID:
26329338
11.

Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence.

Patkar AA, Mannelli P, Peindl K, Hill KP, Wu LT, Lee T, Kuhn C.

J Psychiatr Res. 2008 Oct;42(14):1213-9. doi: 10.1016/j.jpsychires.2008.01.008. Epub 2008 Mar 5.

PMID:
18321529
12.

Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence.

Patkar AA, Mannelli P, Certa KM, Peindl K, Murray H, Vergare MJ, Berrettini WH.

Psychopharmacology (Berl). 2004 Oct;176(1):74-81. Epub 2004 Apr 3.

PMID:
15064918
13.

Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid.

Vethe NT, Ali AM, Reine PA, Andersen AM, Bremer S, Line PD, Rootwelt H, Bergan S.

Ther Drug Monit. 2014 Feb;36(1):108-18. doi: 10.1097/FTD.0b013e3182a13900.

PMID:
24061448
14.

Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence.

Patkar AA, Mannelli P, Hill KP, Peindl K, Pae CU, Lee TH.

Hum Psychopharmacol. 2006 Aug;21(6):367-75.

PMID:
16915581
15.

Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile.

Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, Zhu H, Dougherty GG, Yao JK, Chen G, Guitart X, Carlson PJ, Neumeister A, Zarate C, Krishnan RR, Manji HK, Drevets W.

Sci Rep. 2012;2:667. Epub 2012 Sep 19.

16.

The relationship between lifetime stress and addiction severity in cocaine-dependent participants.

Mahoney JJ 3rd, Newton TF, Omar Y, Ross EL, De La Garza R 2nd.

Eur Neuropsychopharmacol. 2013 May;23(5):351-7. doi: 10.1016/j.euroneuro.2012.05.016. Epub 2012 Jun 28.

PMID:
22748418
18.

Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease.

Barnes VM, Kennedy AD, Panagakos F, Devizio W, Trivedi HM, Jönsson T, Guo L, Cervi S, Scannapieco FA.

PLoS One. 2014 Aug 18;9(8):e105181. doi: 10.1371/journal.pone.0105181. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e114091.

19.

Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals.

Brady KT, McRae AL, Moran-Santa Maria MM, DeSantis SM, Simpson AN, Waldrop AE, Back SE, Kreek MJ.

Arch Gen Psychiatry. 2009 Apr;66(4):422-30. doi: 10.1001/archgenpsychiatry.2009.9.

20.

Relationship between platelet serotonin uptake sites and treatment outcome among African-American cocaine dependent individuals.

Patkar AA, Gottheil E, Berrettini WH, Thornton CC, Hill KP, Weinstein SP.

J Addict Dis. 2003;22(1):79-92.

PMID:
12661981

Supplemental Content

Support Center